About PrEP

Advocacy starts with information. Learn more about how PrEP works, how to get it and more.


Daily oral PrEP works if you take it. That’s the bottom line about this prevention strategy, rolling out with tenofovir-based drugs in countries and communities worldwide.


Explore this section to learn about:

  • The Basics—Get simple, straightforward information about what PrEP is, why it’s clear it works, and how it’s being used.
  • Evidence and Research—Trials have shown that daily oral PrEP works if taken correctly and consistently. But there’s still a lot to learn about new PrEP agents and how to deliver oral PrEP.
  • Introductory Materials—Recommended basic resources for learning more about PrEP

Want something specific? Visit the AVAC Resource Database, where you may search using assorted parameters and keywords.

News Spotlight

  • A Daily Pill Can Prevent HIV Infections. Why Don’t More People Use It?

    March 9, 2018

    There’s no question that a simple regimen of a single daily pill can slash HIV infections in people at risk. But although millions of people around the world could benefit, only 200,000 are prescribed PrEP, and 75 percent of them are in the United States. The disparity was the focus of anguished discussions this week at the largest annual US HIV/AIDS conference.

    Read more

  • Mapping PrEP: First ever data on PrEP users across the US

    March 6, 2018

    The Center for AIDS Research at Emory University's Rollins School of Public Health produces interactive online maps with visualized data on different aspects of the US HIV epidemic, and its prevention and treatment response, at AIDSVu.org. This set of maps and statistics focuses on PrEP use nationally and by state from 2012-2016.

    Read more